Volume 5, Issue 4 (3-2019)                   NBR 2019, 5(4): 372-378 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Salehghamari E, Hosseini M, Taheri F. Isolation of antibacterial material-producing bacteria from saline soil. NBR 2019; 5 (4) :372-378
URL: http://nbr.khu.ac.ir/article-1-3047-en.html
Uni kharazmi , ensiehsalehghamari@gmail.com, esaleh@khu.ac.ir
Abstract:   (4191 Views)
Saline soils are widely spread in Iran. These intact soils are a great source for the isolation of new bacteria with highly functional metabolites in biotechnology. Actinomycete strains were isolated on starch casein agar and ISP2 with different concentrations of sodium chloride (0, 5 and 10%) from treated soil samples. Pure colonies were cultured on a casein glycerol medium. After complete growth, the plates were covered with a thin layer of Muller Hinton Agar (1%) containing methicillin-resistant Staphylococcus aureus (MRSA). Active metabolites of selected strains were extracted and their antibacterial activities analyzed by agar well diffusion method. 38% of isolates produced antibiotics against the pathogen. The metabolites produced by act-2 and act-5 isolates, which had a more effective inhibition zone against MRSA, were extracted and anti MRSA activity of act-5 extract was shown. The antimicrobial activity of act-5 against other bacteria was also investigated and the bacterium was identified. In this study halophilic actinomycetes producing bioactive compounds were isolated from the saline soils of Qom and the anti-MRSA potential of their metabolites was investigated for the first time. The results of this study show the potential of saline soil actinomycetes for the production of useful metabolites.


 
Full-Text [PDF 708 kb]   (979 Downloads)    
Type of Study: Original Article | Subject: Microbiology
Received: 2018/01/3 | Revised: 2019/04/6 | Accepted: 2018/06/20 | Published: 2019/03/18 | ePublished: 2019/03/18

References
1. Bredholt, H., Fjærvik, E., Johnsen, G., and S. B. Zotchev. S. B. 2008. Actinomycetes from sediments in the Trondheim fjord, Bredholt, H., Fjærvik, E., Johnsen, G. and Zotchev. S.B. 2008. Actinomycetes from sediments in the Trondheim fjord, Norway: diversity and biological activity. – Mar. Drugs 6: 12-24. [DOI:10.3390/md6010012]
2. Demain, A.L. and Sanchez, S. 2009. Microbial drug discovery: 80 years of progress. – J. Antibiotics 62: 5. [DOI:10.1038/ja.2008.16]
3. Claverias, F.P., Undabarrena, A., Gonzalez, M., Seeger, M. and Camara B. 2015. Culturable diversity and antimicrobial activity of Actinobacteria from marine sediments in Valparaísobay. Chile. – Front. Microb. 6: 737-743. [DOI:10.3389/fmicb.2015.00737]
4. Fischbach, M.A. and Walsh, C.T. 2009 Antibiotics for emerging pathogens. – Science. 325: 1089-1093. [DOI:10.1126/science.1176667]
5. Gurung, T.D., Sherpa, C., Agrawal, V.P. and Lekhak B. 2009. Isolation and characterization of antibacterial actinomycetes from soil samples of Kalapatthar, Mount Everest Region. – Nepal J. Sci. Technol. 10: 173-182. [DOI:10.3126/njst.v10i0.2957]
6. Iwai, Y. and Omura S. 1992. Cultural conditions for screening of new antibiotics. – J. Antibiot. 34: 123-141.
7. Jenifer, J.S.C.A., Donio, M.T.B.S., Viji, V.T., Velmurugan, S., Babu, M.M., Dhas, S.A. and Citarasu T. 2013. Halo-alkaliphilic actinomycetes from solar salt works in India: diversity and antimicrobial activity. – Blue Biotechnol. J. 2: 137-142.
8. Kieser, T., Bibb, M.J., Buttner, M.J., Chater, K.F. and Hopwood, D.A. 2000. Practical Streptomyces Genetics. Crowes, Norwich, England.
9. Mohammadi, A., Calagari, M., Ladan-Moqaddam, AR. and Mirakhori, R. 2013. Investigation on growth and physiological characteristics of Populus euphratica Oliv. Provenances at Garmsar Desert Station. – Iran. J. For. Poplar Res. 21: 115-125
10. Ramesh, S. and Mathivanan, N. 2009. Screening of marine actinomycetes isolated from the Bay of Bengal, India for antimicrobial activity and industrial enzymes. – World. J. Microb. Biot. 25: 2103-2111. [DOI:10.1007/s11274-009-0113-4]
11. Saadoun, I. and Muhana, A. 2008. Optimal production conditions, extraction, partial purification and characterization of inhibitory compound(s) produced by Streptomyces Ds-104 isolate against multi-drug resistant Candida albicans. – Curr. Trends Biotechnol. Pharm. 2: 402-420.
12. Sharma, D., Kaur, T., Chadha, B.S. and Manhas, R.K. 2011. Antimicrobial activity of actinomycetes against multidrug resistant Staphylococcus aureus, E. coli and various other pathogens. – Trop. J. Pharm. Res. 10: 801-808. [DOI:10.4314/tjpr.v10i6.14]
13. Singh, L.S., Baruah, I. and Bora, T.C. 2006. Actinomycetes of Loktak habitat: isolation and screening for antimicrobial activities. – Biotechnol. 5: 217-221. [DOI:10.3923/biotech.2006.217.221]
14. Trabelsi, I., Oves, D., Manteca, A., Genilloud, O., Altalhi, A. and Nour, M. 2016. Antimicrobial activities of some Actinomycetes isolated from different rhizospheric soils in Tunisia. – Curr. Microbial. 73: 220-227. [DOI:10.1007/s00284-016-1053-5]
15. Ventosa, A., and Nieto. J.J. and Oren, A. 1998. Biology of moderately halophilic aerobic bacteria. – Microbiol. Mol. Biol. Rev. 62: 504-544.
16. Xue, L., Xue, Q., Chen, Q., Lin, C., Shen, G. and Zhao, J. 2013. Isolation and evaluation of Rhizosphere actinomycetes with potential application for biocontrol of Verticillium wilt of cotton. – Crop Prot. 43: 231-240. [DOI:10.1016/j.cropro.2012.10.002]
17. Yin, J., and Chen, J.C. and Wu, Q. and Chen, G.Q. 2015. Halophiles, coming stars for industrial biotechnology. – Biotechnol. Adv. 33: 1433-1442. [DOI:10.1016/j.biotechadv.2014.10.008]
18. Zhu, H., Swierstra, J., Wu, C., Girard, G., Choi, Y.H., Wamel, W.V., Sandiford, S.K. and Wezel, G.P. 2014. Eliciting antibiotics active against the ESKAPE pathogens in a collection of actinomycetes isolated from mountain soils. – Microbiol. 160: 1714-1726. [DOI:10.1099/mic.0.078295-0]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.



© 2024 CC BY-NC 4.0 | Nova Biologica Reperta

Designed & Developed by : Yektaweb